Generic Injectables Market Size to Reach US$ 70.4 Billion by 2028, at a Growth Rate of (CAGR) 8.3%

IMARC Group, a leading market research company, has recently releases report titled "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global generic injectables market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the generic injectables market?

• Market Size in 2022: US$ 43.9 Billion
• Market Forecast in 2028: US$ 70.4 Billion
• Growth rate (2023 to 2028): CAGR of 8.3%
• Base Year of the Analysis: 2022
• Forecast Period: 2023-2028

What are generic injectables?

Generic injectables are pharmaceutical products that are identical or bioequivalent to the original branded injectable products but are marketed under a different brand name after the patent for the original product expires. They are manufactured using the same active pharmaceutical ingredients as the original product and are typically sold at a lower price than the branded product. They are widely used to treat various medical conditions such as cancer, infectious diseases, and autoimmune disorders. They are used in hospitals, clinics, and other medical facilities and are administered through intravenous, intramuscular, or subcutaneous routes.

Request for a free sample copy of this report: https://www.imarcgroup.com/generic-injectables-market/requestsample

What are the growth prospects and trends in the generic injectables industry?

The global market is majorly driven by the increasing demand for affordable healthcare products and services. In line with this, the expiration of patents for many branded injectable products is significantly contributing to the market. Furthermore, the growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disease is positively influencing the market. Apart from this, the expansion of the global pharmaceutical industry is creating a positive outlook for the market. Moreover, the escalating generic drug utilization and rapid technological advancements in manufacturing processes are catalyzing the market. Besides, the increasing demand for biosimilars is offering numerous opportunities for the market. Additionally, the trend toward personalized medicine is accelerating the development of new injectable treatments that can be customized to individual patient needs.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/generic-injectables-market

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Therapeutic Area:

• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Breakup by Container:

• Vials
• Ampoules
• Premix
• Prefilled Syringes

Breakup by Distribution Channel:

• Hospitals
• Retail Pharmacy

Regional Insights:

• Europe
• North America
• Asia
• South America
• Others

Who are the key players operating in the industry?
The report covers the major market players including:

• Hospira (Pfizer)
• Fresenius Kabi
• Hikma
• Sandoz (Novartis)
• Sagent
• Sanofi
• Baxter

Also, Read the Top Players in the Generic Injectables Companies: https://www.imarcgroup.com/generic-injectables-companies

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Other Reports of IMARC Group:

• https://techvizaca.com/2023/05/02/wi-fi-analytics-market-outlook-industry-growth-report-2022-2027/
• https://techvizaca.com/2023/05/02/analgesics-market-growth-analysis-industry-share-size-report-2023-2028/
• https://techvizaca.com/2023/05/02/automotive-glass-market-demand-trends-analysis-outlook-industry-report-2023-2028/
• https://techvizaca.com/2023/05/02/beauty-and-personal-care-products-market-trends-growth-overview-report-2023-2028/
• https://techvizaca.com/2023/05/02/camping-tent-market-outlook-industry-share-size-report-2022-2027/

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.